Insider Transactions in Q2 2020 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q2 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 15
2020
|
Dinesh C Paliwal Director |
BUY
Open market or private purchase
|
Direct |
9,174
+29.33%
|
$495,396
$54.5 P/Share
|
Jun 14
2020
|
Julia A Haller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
558
+7.56%
|
-
|
Jun 14
2020
|
Michael W Bonney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
558
+6.06%
|
-
|
Jun 13
2020
|
Julia A Haller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
903
+12.6%
|
-
|
Jun 13
2020
|
Michael W Bonney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
903
+10.04%
|
-
|
Jun 03
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
738
-8.58%
|
$44,280
$60.21 P/Share
|
Jun 03
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,154
+20.03%
|
-
|
Jun 03
2020
|
Julia A Haller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,949
+35.5%
|
-
|
Jun 03
2020
|
Michael W Bonney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,949
+29.09%
|
-
|
May 22
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Open market or private sale
|
Direct |
3,200
-16.59%
|
$195,200
$61.01 P/Share
|
May 19
2020
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Open market or private sale
|
Direct |
25,000
-48.28%
|
$1,550,000
$62.68 P/Share
|
May 01
2020
|
Nadim Ahmed EVP and President, Hematology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,433
-5.22%
|
$85,980
$60.26 P/Share
|
May 01
2020
|
Nadim Ahmed EVP and President, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct |
2,908
+9.57%
|
-
|
May 01
2020
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
5,274
-8.93%
|
$316,440
$60.26 P/Share
|
May 01
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10,707
+15.35%
|
-
|